Human Metabolome Technologies, Inc. provided consolidated earnings guidance for the fiscal year ending June 2023. For the year, the company expects net sales of JPY 1,300 million, operating profit of JPY 240 million, profit attributable to owners of parent JPY 270 million and basic earnings per share of JPY 45.76.